HealthDay News — Vaccination with the pentavalent rotavirus vaccine (RV5, Rotateq, Merck) did not increase intussusception risk among infants aged 4 to 34 weeks compared with infants who did not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback